The study is a three-arm design where up to 600 patients hospitalized post-MI are recruited
from a large hospital and randomized to either the education group (control group) or one of
the two intervention groups. Patients randomized to one of the intervention groups will
receive a nurse-administered intervention plus the use of Microsoft's HealthVault web-based
platform or solely the use of Microsoft's HealthVault web-based platform and web-based
behavioral intervention, both of which includes a behavioral/medication management component.
The 12 months effects of the intervention will be evaluated.
For baseline and outcome assessments we will obtain BP, nonfasting LDL, and Hb A1c. Patients
will also be surveyed about demographics and health behaviors during the baseline and 12
months. Study personnel serve as a liaison between subjects and their providers; however, all
decisions related to clinical care are ultimately left up to the patient's provider. Subjects
with serious adverse effects will be advised and assisted in seeking emergency medical care.